166 related articles for article (PubMed ID: 33051479)
1. Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35.
Dausset C; Bornes S; Miquel S; Kondjoyan N; Angenieux M; Nakusi L; Veisseire P; Alaterre E; Bermúdez-Humarán LG; Langella P; Engel E; Forestier C; Nivoliez A
Sci Rep; 2020 Oct; 10(1):17074. PubMed ID: 33051479
[TBL] [Abstract][Full Text] [Related]
2. Elemental sulfur enhances the anti-fungal effect of Lacticaseibacillus rhamnosus Lcr35.
Kaur M; Miquel S; Ollivier-Nakusi L; Thoral C; Vareille-Delarbre M; Bekirian C; d'Enfert C; Fontaine T; Roget K; Forestier C
Microbes Infect; 2024; 26(3):105286. PubMed ID: 38160785
[TBL] [Abstract][Full Text] [Related]
3. Comparative phase I randomized open-label pilot clinical trial of Gynophilus
Dausset C; Patrier S; Gajer P; Thoral C; Lenglet Y; Cardot JM; Judlin P; Ravel J; Nivoliez A
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1869-1880. PubMed ID: 30032443
[TBL] [Abstract][Full Text] [Related]
4. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
J Appl Microbiol; 2015 May; 118(5):1180-90. PubMed ID: 25688886
[TBL] [Abstract][Full Text] [Related]
5. Influence of manufacturing processes on in vitro properties of the probiotic strain Lactobacillus rhamnosus Lcr35®.
Nivoliez A; Camares O; Paquet-Gachinat M; Bornes S; Forestier C; Veisseire P
J Biotechnol; 2012 Aug; 160(3-4):236-41. PubMed ID: 22542933
[TBL] [Abstract][Full Text] [Related]
6. Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens.
Coudeyras S; Jugie G; Vermerie M; Forestier C
Infect Dis Obstet Gynecol; 2008; 2008():549640. PubMed ID: 19190778
[TBL] [Abstract][Full Text] [Related]
7. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans.
Köhler GA; Assefa S; Reid G
Infect Dis Obstet Gynecol; 2012; 2012():636474. PubMed ID: 22811591
[TBL] [Abstract][Full Text] [Related]
8. Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights.
Poupet C; Saraoui T; Veisseire P; Bonnet M; Dausset C; Gachinat M; Camarès O; Chassard C; Nivoliez A; Bornes S
PLoS One; 2019; 14(11):e0216184. PubMed ID: 31693670
[TBL] [Abstract][Full Text] [Related]
9. Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome.
Oerlemans EFM; Bellen G; Claes I; Henkens T; Allonsius CN; Wittouck S; van den Broek MFL; Wuyts S; Kiekens F; Donders GGG; Lebeer S
Sci Rep; 2020 May; 10(1):7976. PubMed ID: 32409699
[TBL] [Abstract][Full Text] [Related]
10. Local Probiotic Therapy for Vaginal Candida albicans Infections.
Kovachev SM; Vatcheva-Dobrevska RS
Probiotics Antimicrob Proteins; 2015 Mar; 7(1):38-44. PubMed ID: 25362524
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
Vicariotto F; Del Piano M; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
[TBL] [Abstract][Full Text] [Related]
12. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
Martinez RC; Franceschini SA; Patta MC; Quintana SM; Candido RC; Ferreira JC; De Martinis EC; Reid G
Lett Appl Microbiol; 2009 Mar; 48(3):269-74. PubMed ID: 19187507
[TBL] [Abstract][Full Text] [Related]
13. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
Martinez RC; Seney SL; Summers KL; Nomizo A; De Martinis EC; Reid G
Microbiol Immunol; 2009 Sep; 53(9):487-95. PubMed ID: 19703242
[TBL] [Abstract][Full Text] [Related]
14. Curative Treatment of Candidiasis by the Live Biotherapeutic Microorganism
Poupet C; Veisseire P; Bonnet M; Camarès O; Gachinat M; Dausset C; Chassard C; Nivoliez A; Bornes S
Microorganisms; 2019 Dec; 8(1):. PubMed ID: 31878039
[TBL] [Abstract][Full Text] [Related]
15. [GynOphilus--a winning relay].
Kovachev S
Akush Ginekol (Sofiia); 2012; 51 Suppl 1():41-4. PubMed ID: 23236678
[TBL] [Abstract][Full Text] [Related]
16.
Dube Y; Khan A; Marimani M; Ahmad A
Can J Microbiol; 2020 Dec; 66(12):733-747. PubMed ID: 32777192
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis.
Pericolini E; Gabrielli E; Ballet N; Sabbatini S; Roselletti E; Cayzeele Decherf A; Pélerin F; Luciano E; Perito S; Jüsten P; Vecchiarelli A
Virulence; 2017 Jan; 8(1):74-90. PubMed ID: 27435998
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus is able to alter the virulence and the sensitivity profile of Candida albicans.
Oliveira VM; Santos SS; Silva CR; Jorge AO; Leão MV
J Appl Microbiol; 2016 Dec; 121(6):1737-1744. PubMed ID: 27606962
[TBL] [Abstract][Full Text] [Related]
19. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.
De Gregorio PR; Parolin C; Abruzzo A; Luppi B; Protti M; Mercolini L; Silva JA; Giordani B; Marangoni A; Nader-Macías MEF; Vitali B
Microb Cell Fact; 2020 Jun; 19(1):133. PubMed ID: 32552788
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of Lactobacillus rhamnosus and Lactobacillus casei on Candida biofilm of denture surface.
Song YG; Lee SH
Arch Oral Biol; 2017 Apr; 76():1-6. PubMed ID: 28063305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
